JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 3
DOI:10.33266/1024-6177-2024-69-3-26-34
L.A. Romodin1, E.I. Yashkina1, A.A. Moskovskij2
Fluorimetric Evaluation of the Effect of Riboxin, Copper Chlorophyllin, Trolox and the Soluble form of Indralin on the Growth Properties of A549 Cells in Culture
1 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
2 Russian Biotechnological University, Moscow, Russia
Contact person: L.A. Romodin, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Currently, cell cultures are most often used as an experimental model system in biological research. However, to correctly plan studies using this model system, many aspects must be taken into account. Thus, to be able to correctly assess the effect of radioprotective drugs on cells, it is first necessary to study the effect of these substances on the properties of cells in culture. And the main property for work using plate readers is the ability of cells to adhere to the bottom of the plate and the rate of cell proliferation. This work is devoted to the study of human riboxin (inosine), copper chlorophyllin, trolox and indralin, the growth properties of cells in a culture based on the A549 cell line - human lung adenocarcinoma. Riboxin, chlorophyllin and trolox are promising compounds that make it possible to study their radioprotective properties. Indralin is a reference classic radioprotector. This process used a water-soluble form containing tartaric acid to allow indralin to dissolve in water. The experiment consisted of incubating A549 cells for 24 hours in a solution of riboxin (inosine), copper chlorophyllin, Trolox or tartaric acid at a concentration of 2 mM or in a mixture of 2 mM tartaric acid and 1.9 mM indralin, followed by assessment of the cell content in the samples compared to cells incubated without the addition of these substances, based on the fluorescence of the Hoechst-33342 dye. An additional experiment with chlorophyllin consisted in incubating cells with chlorophyllin already attached to the bottom of the tablet in the concentration range of 50–500 μM for 2.5 hours, followed by an assessment of the content of the remaining cells in the tablet. All studied substances statistically significantly reduced the cell content in the samples compared to the control. The greatest decrease in cell content was observed in the sample with chlorophyllin, and the least – with riboxin. As a result of additional experience in incubating already attached cells in chlorophyllin solution with concentrations of 50–500 μM, it was shown that this substance dose-dependently inhibits the adhesive properties of cells of the A549 line. At the same time, chlorophyllin already at a concentration of 50 μM statistically significantly reduced the cell content in the sample after washing the wells of the tablet compared with the control sample.
The decrease in cell content in the sample containing a mixture of indralin and tartaric acid was statistically significantly more pronounced than that caused by incubation in a solution of tartaric acid alone. That is, the recognized radioprotector indralin demonstrated a pronounced inhibition of the growth properties of the A549 cell line. Based on the information obtained, we can conclude that when planning future studies of the substances studied in this work on a cell culture model, it is necessary to take into account the fact that they inhibit the growth of the cell culture.
Keywords: cell culture, A549, riboxin, copper chlorophyllin, trolox, indralin, tartaric acid, influence estimation
For citation: Romodin LA, Yashkina EI, Moskovskij AA. Fluorimetric Evaluation of the Effect of Riboxin, Copper Chlorophyllin, Trolox and the Soluble form of Indralin on the Growth Properties of A549 Cells in Culture. Medical Radiology and Radiation Safety. 2024;69(3):26–34. (In Russian). DOI:10.33266/1024-6177-2024-69-3-26-34
References
1. Lei G., Zhang Y., Koppula P., Liu X., Zhang J., Lin S.H., Ajani J.A., Xiao Q., Liao Z., Wang H., Gan B. The Role of Ferroptosis in Ionizing Radiation-Induced Cell Death and Tumor Suppression. Cell Research. 2020;30:146–162. doi: 10.1038/s41422-019-0263-3.
2. Raitanen J., Barta B., Hacker M., Georg D., Balber T., Mitterhauser M. Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells. 2023;12;3:360. doi: 10.3390/cells12030360.
3. Jooyan N., Mortazavi S.M.J., Goliaei B., Faraji-Dana R. Indirect Effects of Interference of Two Emerging Environmental Contaminants on Cell Health: Radiofrequency Radiation and Gold Nanoparticles. Chemosphere. 2024;349:140942. doi: 10.1016/j.chemosphere.2023.140942.
4. Pustovalova M., Astrelina capital Te C., Grekhova A., Vorobyeva N., Tsvetkova A., Blokhina T., Nikitina V., Suchkova Y., Usupzhanova D., Brunchukov V., Kobzeva I., Karaseva capital Te C., Ozerov I.V., Samoylov A., Bushmanov A., Leonov S., Izumchenko E., Zhavoronkov A., Klokov D., Osipov A.N. Residual GammaH2AX Foci Induced by Low Dose X-Ray Radiation in Bone Marrow Mesenchymal Stem Cells Do Not Cause Accelerated Senescence in the Progeny of Irradiated Cells. Aging. 2017;9;11:2397–2410. doi: 10.18632/aging.101327.
5. Romodin L.A., Yashkina E.I., Moskovskiy A.A. Fluorimetric Evaluation of the Effect of Malic, Succinic and Ascorbic Acids on the Growth Properties of A549 Cells in Culture. Medical Radiology and Radiation Safety. 2024;69;1:28–32 (In Russ.). doi: 10.33266/1024-6177-2024-69-1-28-32.
6. Sycheva L.P., Rozhdestvenskiy L.M., Lisina N.I., Shlyakova T.G., Zorin V.V. Antimutagenic Activity and Hepatoprotective Effect of Anti-Radiation Drugs. Medical Genetics. 2020;19;9(218):81–82 (In Russ.). doi: 10.25557/2073-7998.2020.09.81-82.
7. Sycheva L.P., Lisina N.I., Shchegoleva R.A., Rozhdestvenskiy L.M. Antimutagenic Effect of Anti-Radiation Drugs in an Experiment on Mice. Radiacionnaya Biologiya. Radioekologiya. 2019;59;4:388–393. (In Russ.). doi: 10.1134/S086980311904012X.
8. Gudkov S.V., Gudkova O.Yu., Shtarkman I.N., Gapeev A.B., Chemeris N.K., Bruskov V.I. Guanosine and Inosine as Natural Geneprotectors for Mice Blood Cells Expo Sed to X-rays. Radiacionnaya Biologiya. Radioekologiya. 2006;46;6:713–718 (In Russ.).
9. Popova N.R., Gudkov S.V., Bruskov V.I. Natural Purine Compounds as Radioprotective Agents. Radiacionnaya Biologiya. Radioekologiya. 2014;54;1:38–49 (In Russ.). doi: 10.7868/S0869803114010135.
10. Hou B., Xu Z.W., Yang C.W., Gao Y., Zhao S.F., Zhang C.G. Protective Effects of Inosine on Mice Subjected to Lethal Total-Body Ionizing Irradiation. Journal of Radiation Research. 2007;48;1:57–62. doi: 10.1269/jrr.06067.
11. Blanco J.M., Caamano O., Fernandez F., Rodriguez-Borges J.E., Balzarini J., de Clercq E. Carbocyclic Analogues of Nucleosides from bis-(Hydroxymethyl)-Cyclopentane: Synthesis, Antiviral and Cytostatic Activities of Adenosine, Inosine and Uridine Analogues. Chemical & Pharmaceutical Bulletin. 2003;51;9:1060–1063. doi: 10.1248/cpb.51.1060.
12. Zerniy E.Yu., Golovastova M.O., Baksheeva V.E., Kabanova E.I., Ishutina I.E., Gancharova O.S., Gusev A.E., Savchenko M.S., Loboda A.P., Sotnikova L.F., Zamyatnin A.A., Philippov P.P., Senin I.I. Alterations in Tear Biochemistry Associated with Chronic Dry Eye Syndrome in Postanesthetic Period. Biohimiya. 2017;82;1:137–148. (In Russ.).
13. McClain D.E., Kalinich J.F., Ramakrishnan N. Trolox Inhibits Apoptosis in Irradiated MOLT-4 Lymphocytes. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 1995;9;13:1345–1354. doi: 10.1096/fasebj.9.13.7557025.
14. Jiang S.J., Xiao X., Li J., Mu Y. Lycium Barbarum Polysaccharide-Glycoprotein Ameliorates Ionizing Radiation-Induced Epithelial Injury by Regulating Oxidative Stress and Ferroptosis Via the Nrf2 Pathway. Free Radical Biology & Medicine. 2023;204:84–94. doi: 10.1016/j.freeradbiomed.2023.04.020.
15. Sangsuwan T., Pour Khavari A., Blomberg E., Romell T., Godoy P., Harms-Ringdahl M., Haghdoost S. Oxidative Stress Levels and DNA Repair Kinetics in Senescent Primary Human Fibroblasts Exposed to Chronic Low Dose Rate of Ionizing Radiation. Frontiers in Bioscience. 2023;28;11:296. doi: 10.31083/j.fbl2811296.
16. Ding S.S., Sun P., Zhang Z., Liu X., Tian H., Huo Y.W., Wang L.R., Han Y., Xing J.P. Moderate Dose of Trolox Preventing the Deleterious Effects of Wi-Fi Radiation on Spermatozoa In vitro through Reduction of Oxidative Stress Damage. Chinese Medical Journal. 2018;131;4:402–412. doi: 10.4103/0366-6999.225045.
17. Zakharova O.D., Frolova T.S., Yushkova Y.V., Chernyak E.I., Pokrovskiy A.G., Pokrovskiy M.A., Morozov S.V., Sinitsina O.I., Grigor’ev I.A., Nevinskiy G.A. Antioxidant and Antitumor Activity of Trolox, Trolox Succinate, and Alpha-Tocopheryl Succinate Conjugates with Nitroxides. European Journal of Medicinal Chemistry. 2016;122:127–137. doi: 10.1016/j.ejmech.2016.05.051.
18. Pozdeev A.V., Lysenko N.P. Increasing the Radiation Resistance of the Mammalian Body when Using Chlorophyll Preparations in Conditions of Radioactive Environmental Pollution. Izvestiya Mezhdunarodnoy Akademii Agrarnogo Obrazovaniya. 2018;42;2:60–62 (In Russ.).
19. Pozdeev A.V., Gugalo V.P. The Effect of Chlorophyll Preparation on the Content of Malondialdehyde in Radiation Pathology. Bulletin of the Kursk State Agricultural Academy. 2012;2:107–109 (In Russ.).
20. Kumar S.S., Shankar B., Sainis K.B. Effect of Chlorophyllin against Oxidative Stress in Splenic Lymphocytes in Vitro and in Vivo. Biochimica et Biophysica Acta. 2004;1672;2:100–111. doi: 10.1016/j.bbagen.2004.03.002.
21. Geric M., Gajski G., Mihaljevic B., Miljanic S., Domijan A.M., Garaj-Vrhovac V. Radioprotective Properties of Food Colorant Sodium Copper Chlorophyllin on Human Peripheral Blood Cells in Vitro. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 2019;845:403027. doi: 10.1016/j.mrgentox.2019.02.008.
22. Morales-Ramirez P., Mendiola-Cruz M.T. In vivo Radioprotective Effect of Chlorophyllin on Sister Chromatid Exchange Induction in Murine Spermatogonial Cells. Mutation Research. 1995;344;1-2:73–78. doi: 10.1016/0165-1218(95)90041-1.
23. Morales-Ramirez P., Garcia-Rodriguez M.C. In vivo Effect Of Chlorophyllin On Gamma-Ray-Induced Sister Chromatid Exchange in Murine Bone Marrow Cells. Mutation Research. 1994;320;4:329–334. doi: 10.1016/0165-1218(94)90085-x.
24. Abraham S.K., Sarma L., Kesavan P.C. Role of Chlorophyllin as an in Vivo Anticlastogen: Protection Against Gamma-Radiation and Chemical Clastogens. Mutation Research. 1994. Vol. 322, № 3. – P.: 209–212. doi: 10.1016/0165-1218(94)90008-6.
25. Zimmering S., Olvera O., Hernandez M.E., Cruces M.P., Arceo C., Pimental E. Evidence for a Radioprotective Effect of Chlorophyllin in Drosophila. Mutation Research. 1990;245;1:47–49. doi: 10.1016/0165-7992(90)90024-e.
26. Romodin L.A., Lysenko N.P. The Radioprotective Effect of Chlorophyll-Based Drugs. Biophysics. 2022;67;1:78–84. doi: 10.1134/S0006350922010158.
27. Chiu L.C., Kong C.K., Ooi V.E. The Chlorophyllin-Induced Cell Cycle Arrest and Apoptosis in Human Breast Cancer MCF-7 Cells is Associated with ERK Deactivation and Cyclin D1 Depletion. International Journal of Molecular Medicine. 2005;16;4:735–740.
28. Chimploy K., Diaz G.D., Li Q., Carter O., Dashwood W.M., Mathews C.K., Williams D.E., Bailey G.S., Dashwood R.H. E2F4 and Ribonucleotide Reductase Mediate S-phase Arrest in Colon Cancer Cells Treated with Chlorophyllin. International Journal of Cancer. 2009;125;9:2086–2094. doi: 10.1002/ijc.24559.
29. Thiyagarajan P., Kavitha K., Thautam A., Dixit M., Nagini S. Dietary Chlorophyllin Abrogates TGFbeta Signaling to Modulate the Hallmark Capabilities of Cancer in an Animal Model of Forestomach Carcinogenesis. Tumour Biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35;7:6725–6737. doi: 10.1007/s13277-014-1849-5.
30. Das J., Samadder A., Mondal J., Abraham S.K., Khuda-Bukhsh A.R. Nano-Encapsulated Chlorophyllin Significantly Delays Progression OF Lung Cancer both in in Vitro and in Vivo Models through Activation of Mitochondrial Signaling Cascades and Drug-DNA Interaction. Environmental Toxicology and Pharmacology. 2016;46:147–157. doi: 10.1016/j.etap.2016.07.006.
31. Sun S., Zhang Y., Xu W., Yang R., Guo J., Guan S., Ma Q., Ma K., Xu J. Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death. Antioxidants. 2021;10;11:1733. doi: 10.3390/antiox10111733.
32. Il’in L.A., Rudnyy N.M., Suvorov N.N., Chernov G.A., Antipov V.V., Vasin M.V., Davydov B.I., Mikhaylov P.P. Indralin – Radioprotektor Ekstrennogo Deystviya. Protivoluchevyye Svoystva, Farmakologiya, Mekhanizm Deystviya, Klinika = Indralin is a Emergency Radioprotector. Anti-Radiation Properties, Pharmacology, Mechanism of Action, Clinic. Moscow Publ., 1994. 436 p. (In Russ.).
33. Vasin M.V. B-190 (Indralin) in the Light of History of Formation of Ideas of the Mechanism of Action of Radioprotectors. Radiacionnaya Biologiya. Radioekologiya. 2020;60;4:378–395 (In Russ.). doi: 10.31857/S0869803120040128.
34. Romodin L.A., Nikitenko O.V., Bychkova T.M., Zrilova Yu.A., Rodionova E.D., Bocharov D.A. Radioprotective Properties of Riboxin (Inosine) and Indralin under External Irradiation. Bulletin of Experimental Biology and Medicine. 2023;176;11:585–588 (In Russ.). doi: 10.47056/0365-9615-2023-176-11-585-588
35. Legeza V.I., Grebenyuk A.N., Zargarova N.I. To a Question on Efficiency of Application of Radioprotectors with Various Mechanisms of Action in Injures Typical for Radiation Accidents (Experimental Research). Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2013;1:42–47 (In Russ.).
36. Grebenyuk A.N., Myasnikov V.A., Zatsepin V.V., Aksenova N.V., Bykov V.N., Sidorov D.A. Comparative Study of the Effectiveness of Heparin, Interleukin-1β, Β-Estradiol and Indometofen as Radioprotectors in Acute Irradiation. Bulletin of the Russian Military Medical Academy. 2011;4(36):101–104 (In Russ.).
37. Filimonova M.V., Shevchenko L.I., Makarchuk V.M., Chesnakova E.A., Izmest’eva O.S., Korneeva T.S., Filimonov A.S. Radioprotective Properties of NO-Synthase Inhibitor T1023: I. Indicators of Radioprotective Activity and Interaction with Other Radioprotectors. Radiacionnaya Biologiya. Radioekologiya. 2015;55;3:250–259 (In Russ.). doi: 10.7868/S0869803115030042.
38. Zhang Y., Huang Q., Xu Q., Jia C., Xia Y. Pimavanserin Tartrate Induces Apoptosis and Cytoprotective Autophagy and Synergizes with Chemotherapy on Triple Negative Breast Cancer. Biomedicine & Pharmacotherapy. 2023;168:115665. doi: 10.1016/j.biopha.2023.115665.
39. Lecureur V., Le Thiec A., Le Meur A., Amiot L., Drenou B., Bernard M., Lamy T., Fauchet R., Fardel O. Potassium Antimonyl Tartrate Induces Caspase- and Reactive Oxygen Species-Dependent Apoptosis in Lymphoid Tumoral Cells. British Journal of Haematology. 2002;119;3:608–615. doi: 10.1046/j.1365-2141.2002.03863.x.
40. Lecureur V., Lagadic-Gossmann D., Fardel O. Potassium Antimonyl Tartrate Induces Reactive Oxygen Species-Related Apoptosis in Human Myeloid Leukemic HL60 Cells. International Journal of Oncology. 2002;20;5:1071–1076.
41. Chang S.H., Lee A.Y., Yu K.N., Park J., Kim K.P., Cho M.H. Dihydroergotamine Tartrate Induces Lung Cancer Cell Death through Apoptosis and Mitophagy. Chemotherapy. 2016;61;6:304–312. doi: 10.1159/000445044.
42. Elmetwalli A., Hashish S.M., Hassan M.G., El-Magd M.A., El-Naggar S.A., Tolba A.M., Salama A.F. Modulation of the Oxidative Damage, Inflammation, and Apoptosis-Related Genes by Dicinnamoyl-L-tartaric Acid in Liver Cancer. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2023;396;11:3087–3099. doi: 10.1007/s00210-023-02511-8.
43. Fuchs H., Jahn K., Hu X., Meister R., Binter M., Framme C. Breaking a Dogma: High-Throughput Live-Cell Imaging in Real-Time with Hoechst 33342. Advanced Healthcare Materials. 2023;12;20:e2300230. doi: 10.1002/adhm.202300230.
44. Cordeiro M.M., Filipe H.A.L., Santos P.D., Samelo J., Ramalho J.P.P., Loura L.M.S., Moreno M.J. Interaction of Hoechst 33342 with POPC Membranes at Different pH Values. Molecules. 2023;28;15:5640. doi: 10.3390/molecules28155640.
45. Vasin M.V., Ushakov I.B. Potential Ways of Increase in Bogy Resistance to Damaging Actionof Ionizing Radiation with the Aids of Radiomitigators. Uspekhi Sovremennoy Biologii. 2019;139;3:235–253 (In Russ.). doi: 10.1134/S0042132419030098.
46. Srinivasan S., Torres A.G., Ribas de Pouplana L. Inosine in Biology and Disease. Genes. 2021;12;4:600. doi: 10.3390/genes12040600.
47. Zhuravlyov A.I., Zubkova S.M. Antioksidanty. Svobodnoradikal’naya Patologiya, Starenie = Antioxidants. Free Radical Pathology, Aging. Second edition, revised and expanded. Moscow, Belye Al’vy Publ., 2014. 304 p. (In Russ.).
48. Zhuravlyov A.I. Kvantovaya Biofizika Zhivotnykh I Cheloveka: Svechenie Zhivykh Tkaney = Quantum Biophysics of Animals and Humans: The Glow of Living Tissues. Moscow, BINOM. Laboratoriya Znaniy Publ., 2014. 400 p. (In Russ.).
49. Hutchison J.C., Evans J., Edgell T.A., Nie G., Gardner D.K., Salamonsen L.A. Detrimental Actions of Obesity-Associated Advanced Glycation End-Products on Endometrial Epithelial Cell Proliferation are Alleviated by Antioxidants. Reproductive Biomedicine Online. 2023;47;1:35–50. doi: 10.1016/j.rbmo.2023.01.021.
50. Raj M.H., Abd Elmageed Z.Y., Zhou J., Gaur R.L., Nguyen L., Azam G.A., Braley P., Rao P.N., Fathi I.M., Ouhtit A. Synergistic Action of Dietary Phyto-Antioxidants on Survival and Proliferation of Ovarian Cancer Cells. Gynecologic Oncology. 2008;110;3:432–438. doi: 10.1016/j.ygyno.2008.05.001.
51. Asay S., Graham A., Hollingsworth S., Barnes B., Oblad R.V., Michaelis D.J., Kenealey J.D. Gamma-Tocotrienol and Alpha-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells. Molecules. 2020;25;2:398. doi: 10.3390/molecules25020398.
52. Liu K.Y., Wang Q., Nakatsu C.H., Jones-Hall Y., Jiang Q. Combining Gamma-Tocopherol and Aspirin Synergistically Suppresses Colitis-Associated Colon Tumorigenesis and Modulates the Gut Microbiota in Mice, and Inhibits the Growth of Human Colon Cancer Cells. European Journal of Pharmacology. 2023;946:175656. doi: 10.1016/j.ejphar.2023.175656.
53. Ardelt B., Kunicki J., Traganos F., Darzynkiewicz Z. Chlorophyllin Protects Cells from the Cytostatic and Cytotoxic Effects of Quinacrine Mustard but Not of Nitrogen Mustard. International Journal of Oncology. 2001;18;4:849–853. doi: 10.3892/ijo.18.4.849.
54. Kouvaris J.R., Kouloulias V.E., Vlahos L.J. Amifostine: the First Selective-Target and Broad-Spectrum Radioprotector. The Oncologist. 2007;12;6:738–747. doi: 10.1634/theoncologist.12-6-738.
55. Buzgan N.G., Semenenko O.F., Dorosevich A.E. Influence of Acetylcholine and Adrenergic Receptors on Development and Progression of Non-Small Cell Lung Cancer. Voprosy Onkologii. 2016;62;5:694–700 (In Russ.).
56. Fatyukhina O.E., Kolokol’tsova T.D., Troshkova G.P. Safety Assessment of the Laser-Induced Fluorescence Method Based on a Human Diploid Cell Culture Model. Kletochnyye Tekhnologii v Biologii i Meditsine. 2007;4:203–206 (In Russ.).
57. Povolyaeva O.S., Chadaeva A.A., Lunitsin A.V., Yurkov S.G. Dwarf bat’s (Pipistrellus Pipistrellus) Lung Diploid Cell Strains and their Permissivity to Orbiviruses (Reoviridae: Orbivirus) – Pathogens of Vector-Borne Animal Diseases. Problems of Virusology. 2022;67;3:227–236 (In Russ.). doi: 10.36233/0507-4088-114.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The research was carried out at the expense of a grant from the Russian Science Foundation No. 23-24-00383, https://rscf.ru/project/23-24-00383 /.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.01.2024. Accepted for publication: 27.02.2024.